BamSEC and AlphaSense Join Forces
Learn More

Astria Therapeutics Inc.

NASDAQ: ATXS    
Share price (1/8/25): $8.35    
Market cap (1/8/25): $471 million

Material Contracts Filter

EX-10.1
from 10-Q 14 pages Astria Therapeutics, Inc. Second Amended and Restated 2015 Stock Incentive Plan
12/34/56
EX-10.19
from 10-K 102 pages Sublease Agreement
12/34/56
EX-10.18
from 10-K 48 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. ​ ​ ​ License Agreement ​ by and Between ​ Ichnos Sciences SA Ichnos Sciences Inc. ​ and ​ Astria Therapeutics, Inc. ​
12/34/56
EX-10.2
from 10-Q 12 pages Astria Therapeutics, Inc. Amended and Restated 2015 Stock Incentive Plan
12/34/56
EX-10.1
from 10-Q 11 pages Master Consulting Agreement
12/34/56
EX-10.8
from 10-Q 14 pages ​ Astria Therapeutics, Inc. Amended and Restated Severance Benefits Plan
12/34/56
EX-10.7
from 10-Q 7 pages ​ Astria Therapeutics, Inc. 2015 Employee Stock Purchase Plan*
12/34/56
EX-10.6
from 10-Q 4 pages ​ Astria Therapeutics, Inc. Nonstatutory Stock Option Agreement
12/34/56
EX-10.5
from 10-Q 4 pages ​ Astria Therapeutics, Inc. Incentive Stock Option Agreement
12/34/56
EX-10.19
from 10-K 173 pages Sublease Agreement
12/34/56
EX-10.10
from 10-K 12 pages Catabasis Pharmaceuticals, Inc. Assumed Warrant to Purchase Shares of Common Stock
12/34/56
EX-10.9
from 10-K 11 pages Catabasis Pharmaceuticals, Inc. Assumed Warrant to Purchase Shares of Preferred Stock
12/34/56
EX-10.3
from 10-K 44 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 25 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 60 pages Stock Purchase Agreement
12/34/56
EX-10.1
from 10-Q 14 pages Catabasis Pharmaceuticals, Inc. Amended and Restated Severance Benefits Plan
12/34/56
EX-10.1
from 10-Q 70 pages Agreements
12/34/56
EX-10.1
from 10-Q 9 pages Fourth Amendment of Lease
12/34/56
EX-10.2
from 10-Q ~5 pages Summary of Non-Employee Director Compensation Program
12/34/56
EX-10.1
from 8-K 3 pages Consulting Agreement
12/34/56